Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Context Therapeutics Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −1 vs. Q2 2025
- Shares held
- 69.0M
- +361.7K (+0.5%) vs. Q2 2025
- Total value
- $66.8M
- +$21.9M (+48.6%) vs. Q2 2025
- New holders
- 6
- 6 more added
- Sold out
- 7
- 7 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 117 | $113 | 0.00% | +4+3.5% | Added |
| Barclays PLC | 167 | $162 | 0.00% | +167 | New |
| Bank of America Corp | 434 | $420 | 0.00% | −109−20.1% | Reduced |
| UBS Group AG | 7,382 | $7.15K | 0.00% | +7,012+1,895.1% | Added |
| XTX Topco Ltd | 10,597 | $10.3K | 0.00% | +10,597 | New |
| Caxton Corp | 18,403 | $17.8K | 0.08% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,000 | $19.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 21,967 | $21.3K | 0.00% | +21,967 | New |
| Advisor Group Holdings, Inc. | 25,500 | $24.6K | 0.00% | +15,000+142.9% | Added |
| Marshall Wace, LLP | 35,750 | $34.7K | 0.00% | +35,750 | New |
| Northern Trust Corp | 66,384 | $64.3K | 0.00% | −47,181−41.5% | Reduced |
| Qube Research & Technologies Ltd | 82,111 | $79.5K | 0.00% | −24,668−23.1% | Reduced |
| Clear Harbor Asset Management, LLC | 92,804 | $89.9K | 0.01% | +35,000+60.5% | Added |
| Velan Capital Investment Management LP | 100,000 | $96.9K | 0.09% | 00.0% | Unchanged |
| Citadel Advisors LLC | 103,363 | $100.1K | 0.00% | +103,363 | New |
| Mill Creek Capital Advisors, LLC | 104,631 | $101.4K | 0.00% | 00.0% | Unchanged |
| Pathstone Holdings, LLC | 110,244 | $106.8K | 0.00% | +110,244 | New |
| HighTower Advisors, LLC | 125,852 | $121.9K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 132,786 | $128.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 152,607 | $147.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 320,127 | $310.1K | 0.00% | −43,803−12.0% | Reduced |
| ADAR1 Capital Management, LLC | 351,094 | $340.1K | 0.03% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 402,653 | $390.1K | 0.04% | −115,372−22.3% | Reduced |
| Geode Capital Management, LLC | 608,577 | $589.9K | 0.00% | −29,233−4.6% | Reduced |
| BlackRock, Inc. | 848,970 | $822.5K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 1,341,636 | $1.30M | 0.33% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,661,950 | $1.61M | 0.10% | −273,534−14.1% | Reduced |
| Alyeska Investment Group, L.P. | 1,663,355 | $1.61M | 0.00% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,440,330 | $2.36M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,495,031 | $3.39M | 0.00% | +134,449+4.0% | Added |
| Franklin Resources Inc | 4,003,380 | $3.88M | 0.00% | 00.0% | Unchanged |
| Great Point Partners LLC | 4,683,711 | $4.54M | 1.89% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 7,407,906 | $7.18M | 2.23% | 00.0% | Unchanged |
| Nextech Invest, Ltd. | 7,419,355 | $7.19M | 1.09% | 00.0% | Unchanged |
| Deep Track Capital, LP | 7,419,355 | $7.19M | 0.20% | 00.0% | Unchanged |
| Avidity Partners Management LP | 8,981,855 | $8.70M | 1.98% | +1,504,600+20.1% | Added |
| MPM Oncology Impact Management LP | 14,705,882 | $14.2M | 2.33% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −680,188−100.0% | Sold out |
| Luminus Management LLC | 0 | $0 | 0.00% | −328,222−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −44,176−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,067−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −7,414−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Congress Wealth Management LLC | – | – | – | – | Not filed |